432 related articles for article (PubMed ID: 26392546)
21. Induction of humoral and cell-mediated immune responses by hepatitis B virus epitope displayed on the virus-like particles of prawn nodavirus.
Yong CY; Yeap SK; Goh ZH; Ho KL; Omar AR; Tan WS
Appl Environ Microbiol; 2015 Feb; 81(3):882-9. PubMed ID: 25416760
[TBL] [Abstract][Full Text] [Related]
22. Vaccine delivery system for tuberculosis based on nano-sized hepatitis B virus core protein particles.
Dhanasooraj D; Kumar RA; Mundayoor S
Int J Nanomedicine; 2013; 8():835-43. PubMed ID: 23486691
[TBL] [Abstract][Full Text] [Related]
23. Folding and assembly of hepatitis B virus core protein: a new model proposal.
Bringas R
J Struct Biol; 1997 Apr; 118(3):189-96. PubMed ID: 9169229
[TBL] [Abstract][Full Text] [Related]
24. Assembly and export determine the intracellular distribution of hepatitis B virus core protein subunits.
Weigand K; Knaust A; Schaller H
J Gen Virol; 2010 Jan; 91(Pt 1):59-67. PubMed ID: 19741067
[TBL] [Abstract][Full Text] [Related]
25. Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine.
Xu J; Guo HC; Wei YQ; Dong H; Han SC; Ao D; Sun DH; Wang HM; Cao SZ; Sun SQ
Appl Microbiol Biotechnol; 2014 Apr; 98(8):3529-38. PubMed ID: 24413974
[TBL] [Abstract][Full Text] [Related]
26. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
Lyu K; He YL; Li HY; Chen R
J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
[TBL] [Abstract][Full Text] [Related]
27. [Preparation and characterization of HBc virus like particles with site-directed coupling function].
Liu D; Li B; Bi C; Qiao H; Wu X
Sheng Wu Gong Cheng Xue Bao; 2020 Jul; 36(7):1440-1449. PubMed ID: 32748602
[TBL] [Abstract][Full Text] [Related]
28. Subunit Protein Vaccine Delivery System for Tuberculosis Based on Hepatitis B Virus Core VLP (HBc-VLP) Particles.
Dhanasooraj D; Kumar RA; Mundayoor S
Methods Mol Biol; 2016; 1404():377-392. PubMed ID: 27076312
[TBL] [Abstract][Full Text] [Related]
29. A structural model for duck hepatitis B virus core protein derived by extensive mutagenesis.
Nassal M; Leifer I; Wingert I; Dallmeier K; Prinz S; Vorreiter J
J Virol; 2007 Dec; 81(23):13218-29. PubMed ID: 17881438
[TBL] [Abstract][Full Text] [Related]
30. Rapid screening and scaled manufacture of immunogenic virus-like particles in a tobacco BY-2 cell-free protein synthesis system.
Armero-Gimenez J; Wilbers R; Schots A; Williams C; Finnern R
Front Immunol; 2023; 14():1088852. PubMed ID: 36776898
[TBL] [Abstract][Full Text] [Related]
31. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
32. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development.
Wu PC; Lin WL; Wu CM; Chi JN; Chien MS; Huang C
Appl Microbiol Biotechnol; 2012 Sep; 95(6):1501-7. PubMed ID: 22526782
[TBL] [Abstract][Full Text] [Related]
33. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
[TBL] [Abstract][Full Text] [Related]
34. Establishment of a yeast-based VLP platform for antigen presentation.
Wetzel D; Rolf T; Suckow M; Kranz A; Barbian A; Chan JA; Leitsch J; Weniger M; Jenzelewski V; Kouskousis B; Palmer C; Beeson JG; Schembecker G; Merz J; Piontek M
Microb Cell Fact; 2018 Feb; 17(1):17. PubMed ID: 29402276
[TBL] [Abstract][Full Text] [Related]
35. A novel virus-like particle based on hepatitis B core antigen and substrate-binding domain of bacterial molecular chaperone DnaK.
Wang XJ; Gu K; Xiong QY; Shen L; Cao RY; Li MH; Li TM; Wu J; Liu JJ
Vaccine; 2009 Dec; 27(52):7377-84. PubMed ID: 19778518
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the disassembly and reassembly of the HBV glycoprotein surface antigen, a pliable nanoparticle vaccine platform.
Gallagher JR; Torian U; McCraw DM; Harris AK
Virology; 2017 Feb; 502():176-187. PubMed ID: 28061386
[TBL] [Abstract][Full Text] [Related]
37. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e.
Tsybalova LM; Stepanova LA; Kuprianov VV; Blokhina EA; Potapchuk MV; Korotkov AV; Gorshkov AN; Kasyanenko MA; Ravin NV; Kiselev OI
Vaccine; 2015 Jun; 33(29):3398-406. PubMed ID: 25976545
[TBL] [Abstract][Full Text] [Related]
38. Major findings and recent advances in virus-like particle (VLP)-based vaccines.
Mohsen MO; Zha L; Cabral-Miranda G; Bachmann MF
Semin Immunol; 2017 Dec; 34():123-132. PubMed ID: 28887001
[TBL] [Abstract][Full Text] [Related]
39. A Modular Vaccine Development Platform Based on Sortase-Mediated Site-Specific Tagging of Antigens onto Virus-Like Particles.
Tang S; Xuan B; Ye X; Huang Z; Qian Z
Sci Rep; 2016 May; 6():25741. PubMed ID: 27170066
[TBL] [Abstract][Full Text] [Related]
40. A preliminary study on the activation and antigen presentation of hepatitis B virus core protein virus-like particle-pulsed bone marrow-derived dendritic cells.
Ding FX; Xian X; Guo YJ; Liu Y; Wang Y; Yang F; Wang YZ; Song SX; Wang F; Sun SH
Mol Biosyst; 2010 Nov; 6(11):2192-9. PubMed ID: 20820487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
